Bringing you the Best Analytical Legal News
Cyril Amarchand Mangaldas advised Linux Laboratories Private Limited on the acquisition of a stake by ChrysCapital and Tata Capital Healthcare Fund III, alongside the exit of Tata Capital Healthcare Fund II.
The divestment was undertaken through on-market block trades on the stock exchanges pursuant to an accelerated bookbuild process, with the units acquired by a range of institutional investors.
The Oxane Partners group is engaged in the business of providing technology-enabled solutions for private credit markets.
The Transaction is expected to close in Q1 2027, subject to receipt of required regulatory approvals and satisfaction of other customary closing conditions.
S&R Associates represented MiddleGround Capital on Indian legal aspects of the sale of Dura Driver Control Systems to Aspire Biopharma Holdings, Inc., a listed U.S. biopharmaceutical company.
The transaction results in a full exit for the Company’s existing shareholders, True North and Temasek, Reeba Chacko, Senior Partner; provided strategic guidance.
Shardul Amarchand Mangaldas & Co. Advises NextGen Invent Corporation on Acquisition by Straive
The deal marks a strategic addition to Straive’s capabilities in the rapidly evolving Data & AI ecosystem and strengthens its ability to deliver enterprise AI solutions across global markets.
The Transaction is structured as an interconnected multi-jurisdictional acquisition, with simultaneous closing across jurisdictions.